Resbiotic

Birmingham, United States Founded: 2021 • Age: 5 yrs
Probiotic supplements are provided to support gut and overall health.

About Resbiotic

Resbiotic is a Healthcare company based in Birmingham (United States) founded in 2021 by C Vivek Lal. Probiotic supplements are provided to support gut and overall health. Resbiotic has raised $19.64 million across 6 funding rounds from investors including HHS, Timberline Holdings and BioStack Ventures. Its chief executive, as recorded, is C Vivek Lal. Its website resbiotic.com draws about 52 thousand monthly visits. Resbiotic offers products and services including resB® Lung Support Probiotic, Power Gut Bundle, resG prebeet® ENERGY Prebiotic, and resM™ GLP-1 Postbiotic. Its focus areas include Life Sciences, Microbiome Therapeutics, Probiotics and Nutraceuticals Tech. Its competitors include Pendulum, Seed and Seres Therapeutics; 3 of its 3 listed competitors have raised funding.

Company details

Resbiotic was founded in 2021 in Birmingham, United States, as a provider in the health supplements sector. Physician-formulated products, including probiotics, prebiotics, and postbiotics, are offered to restore gut health and aid lung, gut, and metabolic functions. Operations focus on delivering these supplements through an online domain, resbiotic.com, targeting wellness needs in the United States.

  • Headquarters Birmingham, United States
  • Founders C Vivek Lal
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website resbiotic.com
  • Social LinkedIn X Facebook Instagram YouTube
Key Metrics
  • Total Equity Funding
    $19.64M (USD)

    in 6 rounds

  • Latest Funding Round
    $8M (USD), Series A

    Sep 2025

  • Investors
    HHS

    & 2 more

Products & Services of Resbiotic

Resbiotic offers a comprehensive portfolio of products and services, including resB® Lung Support Probiotic, Power Gut Bundle, resG prebeet® ENERGY Prebiotic, and resM™ GLP-1 Postbiotic.

resB® Lung Support Probiotic
Probiotic Supplement

Supports lung health with scientifically formulated probiotics.

Power Gut Bundle
Health Bundle

Combines probiotics for comprehensive gut health support.

resG prebeet® ENERGY Prebiotic
Prebiotic Supplement

Enhances energy and gut function through prebiotic fibers.

resM™ GLP-1 Postbiotic
Postbiotic Supplement

Aids metabolic health with postbiotic compounds.

Apps and channels of Resbiotic

its YouTube channel res • probiotics & prebiotics has 101 subscribers and 10 videos.

res • probiotics & prebiotics
YouTube 101 subscribers 10 videos Science & Technology
Open channel

Videos from Resbiotic

The most watched videos on Resbiotic's YouTube channel, res • probiotics & prebiotics (101 subscribers). Click a video to play it here.

ResBiotic and the Gut Lung Axis
1.1K views
Why Don Takes resB® Lung Support
494 views
Why Allison Takes resB® Lung Support
309 views
A Registered Dietitian Reviews prebeet ENERGY+
225 views

More on res • probiotics & prebiotics.

Funding Insights of Resbiotic

Resbiotic has successfully raised a total of $19.64M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $8 million completed in September 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $19.64M
  • Total Rounds 6
  • Last Round Series A — $8M
  • First Round $3M

    (Apr 2021)

  • Investors Count 3

All 6 funding rounds of Resbiotic with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2025$8MSeries A––
Feb 2025$1.5MSeed––
–
Jan 2024$2.64MSeed––
–
Mar 2023$1.3MGrant––
Oct 2021$4.5MSeed––
–
Apr 2021$3MSeed–Timberline
–
Valuation history

3 investors in total: 3 institutional.

Investors in Resbiotic

Resbiotic has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Timberline Holdings and BioStack Ventures.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Timberline Holdings is focused on family investment and growth.
2010timberlineholdings.comBirmingham, United States
Public health and human services are overseen by HHS.
1953hhs.gov
biostackventures.com
Premium access

Investor details for Resbiotic

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Resbiotic

4 people are tracked at Resbiotic (4 in leadership).

NameRoleGroup
C Vivek Lal
Founder & CEOLeadership
Amit Gaggar
Chief Medical OfficerLeadership
MANI KUKREJA
Director of Integrative Health and Wellness at ResBiotic.Leadership
Stefany N.
Executive Vice President Of GrowthLeadership
Premium access

Complete people profiles for Resbiotic

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Resbiotic

3 dated milestones of Resbiotic across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded Resbiotic is founded.
  2. Funding First funding round of $3.0M.
  3. Funding Latest funding round, Series A, of $8.0M.

Competitors of Resbiotic

Resbiotic has 3 listed competitors in our database, 3 of them funded. They include Pendulum, Seed and Seres Therapeutics.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
pendulumlife.com2012San Francisco, United States$109.5M55
Pendulum is focused on developing advanced probiotic solutions.
seed.com2016Los Angeles, United States$40.62M
Synbiotics are developed for simulating the gut microbiome.
serestherapeutics.com2010Cambridge, United States$257.13M332
Microbiome therapeutics are developed to address diverse diseases.
Premium access

Detailed competitors of Resbiotic

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Resbiotic

The website of Resbiotic (resbiotic.com) receives about 51.9K visits a month.

  • Monthly visits
    51.9K

    ▲ 76.2% vs previous month

Similar websites

Websites whose visitors overlap most with Resbiotic. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
veracityselfcare.com
100%
1.5K#10,831,585View details
humnutrition.com
84%
513.8K#147,041View details
hellowisp.com
81%
1.2M#38,980View details
shop.mallofamerica.com
shop.mallofamerica.com
48%
#537,269–
advancedmolecularlabs.com
advancedmolecularlabs.com
26%
#2,190,068–

Top companies in Microbiome Therapeutics

3 companies that operate in the same segment as Resbiotic (Microbiome Therapeutics) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Pendulum is focused on developing advanced probiotic solutions.
2012San Francisco, California, United StatesUSD 109.5 M55
Microbiome-based therapeutics for skin conditions like eczema are developed.
2014Farmington, United StatesUSD 37.4 M12
Engineered microbes are developed as programmable therapeutics for metabolic disorders.
2013Cambridge, Massachusetts, United StatesUSD 34.4 MUSD 8 K1
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • âś“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • âś“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • âś“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Resbiotic

Resbiotic Launches Nationwide at GNC
Nutraceuticalsworld • 2 years ago
ResBiotic expands portfolio with prebeet Energy+
Nutraingredients-Usa • 2 years ago
ResBiotic Raises $3M in Seed Funding
Finsmes • 5 years ago
Premium access

Complete news archive for Resbiotic

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Resbiotic

Resbiotic was founded in 2021.

Resbiotic is headquartered in Birmingham, United States. It is registered at Birmingham, Alabama, United States.

C Vivek Lal is the CEO of Resbiotic, as recorded in our data. They have also founded this company.

Resbiotic is a funded company, having raised a total of $19.64M across 6 funding rounds to date. The company's 1st funding round was a Seed of $3M, raised on Apr 2021.

Resbiotic was founded in 2021 in Birmingham, United States, as a provider in the health supplements sector. Physician-formulated products, including probiotics, prebiotics, and postbiotics, are offered to restore gut health and aid lung, gut, and metabolic functions. Operations focus on delivering these supplements through an online domain, resbiotic.com, targeting wellness needs in the United States.

Resbiotic's top competitors include Pendulum, Seres Therapeutics and Seed.

Resbiotic offers resB® Lung Support Probiotic, Power Gut Bundle, resG prebeet® ENERGY Prebiotic, and resM™ GLP-1 Postbiotic.

Resbiotic has 3 investors. Key investors include HHS, Timberline Holdings, and BioStack Ventures.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available